• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS D-DIMER; FIBRIN SPLIT PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS D-DIMER; FIBRIN SPLIT PRODUCTS Back to Search Results
Catalog Number 04912551190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/23/2021
Event Type  malfunction  
Manufacturer Narrative
Results can differ between tests due to different specificity of the antibody used or other test characteristics.D-dimer is not a standardized analyte and results generated using different d-dimer assays are not necessarily identical due to factors such as (but not limited to): reactivity/specificity of different antibodies.Epitope expression during fibrin formation and degradation.Heterogeneity of the fibrin degradation products in plasma.Calibrator material.Variation in optical detection ability between different instruments.Assay formats (latex bead size and required wavelengths).Interference by other analytes (e.G.Rheumatoid factor (rf), mouse monoclonal antibodies.The investigation could not identify a product problem.This event occurred in (b)(6).Udi number = (b)(4).
 
Event Description
The initial reporter stated they received discrepant results for two samples collected from the same patient and tested with d-di tina-quant d-dimer gen.2 on a cobas 6000 c (501) module.No incorrect results were reported outside of the laboratory.The reporter stated that since the patient was recovering, was stable, and il6 values dropped from a previous value of 9.76 (no units provided) to 2.15, it was expected that d-dimer values would drop as well.The first sample resulted in a d-dimer value of 4006 ng/ml when tested on the c 501 analyzer.The sample was repeated on a vidas analyzer, resulting in a value of 278.39 ng/ml.The second sample resulted in a d-dimer value of 3848 ng/ml when tested on the c 501 analyzer.The sample was repeated on a vidas analyzer, resulting in a value of 284.81.This sample was then diluted 1:5 and repeated on the c 501 analyzer, resulting in a value of 7049 ng/ml on (b)(6) 2021.The sample was also diluted 1:10 and repeated on the c 501 analyzer, resulting in a value of 6904 ng/ml on (b)(6) 2021.The third sample resulted in a d-dimer value of 3709 ng/ml when tested on the c 501 analyzer on (b)(6) 2021.When repeated on a vidas analyzer, this sample resulted in a value of 346.36 ng/ml.The sample was also repeated on a horiba pentra 400 system, resulting in a value of 294 ng/ml.The serial number of the c 501 analyzer is (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
D-DIMER
Type of Device
FIBRIN SPLIT PRODUCTS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key11677067
MDR Text Key245756958
Report Number1823260-2021-01156
Device Sequence Number1
Product Code GHH
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K062203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue Number04912551190
Device Lot Number509145
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/25/2021
Initial Date FDA Received04/16/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CROCIN ("SOS ON FEVER").; DOXY TABLET (ONE TAB AFTER BREAKFAST FOR 5 DAYS).; LUPENOX INJECTION.; PAN (BEFORE BREAKFAST FOR 10 DAYS).; REMDESIVIR INJECTION.; VITAMIN C TABLET (ONE AT 8 A.M., ONE AT 8 P.M.).; ZINC TABLET (ONE AT 8 A.M.).
-
-